IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLCGARPConcentrated trader

CIK: 0001703031 | Boston, MA

Q1 2026 vs Q2 2026 ComparisonProfile

Filing History

QuarterForm TypeHoldingsValueFiledSEC
Q2 2026
13F-HR21$1.7B2026-08-14SEC ↗
Q1 2026
13F-HR20$1.1B2026-05-15SEC ↗
Q4 2025
13F-HR19$1.3B2026-02-17SEC ↗
Q3 2025
13F-HR21$1.5B2025-11-14SEC ↗
Q2 2025
13F-HR23$799.3M2025-08-14SEC ↗
Q1 2025
13F-HR24$675.9M2025-05-15SEC ↗
Q4 2024
13F-HR26$850.1M2025-02-14SEC ↗
Q3 2024
13F-HR24$961.2M2024-11-14SEC ↗
Q2 2024
13F-HR25$910.8M2024-08-12SEC ↗
Q1 2024
13F-HR26$1.2B2024-05-15SEC ↗
Q4 2023
13F-HR27$1.0B2024-02-13SEC ↗
Q3 2023
13F-HR31$894.2M2023-11-14SEC ↗
Q2 2023
13F-HR32$971.0M2023-08-14SEC ↗
Q1 2023
13F-HR34$132.8M2023-05-15SEC ↗
Q4 2022
13F-HR33$148.3M2023-02-14SEC ↗
Q3 2022
13F-HR33$198.9M2022-11-14SEC ↗
Q2 2022
13F-HR35$202.2M2022-08-15SEC ↗
Q1 2022
13F-HR34$232.9M2022-05-16SEC ↗
Q4 2021
13F-HR34$267.6M2022-02-14SEC ↗
Q3 2021
13F-HR33$500.0M2021-11-15SEC ↗
Q2 2021
13F-HR30$397.1M2021-08-16SEC ↗
Q1 2021
13F-HR31$630.4M2021-05-17SEC ↗
Q4 2020
13F-HR26$498.3M2021-02-16SEC ↗
Q3 2020
13F-HR22$232.2M2020-11-16SEC ↗
Q2 2020
13F-HR15$139.9M2020-08-14SEC ↗
Q1 2020
13F-HR11$119.1M2020-05-15SEC ↗
Q4 2019
13F-HR10$670.5K2020-02-14SEC ↗
Q3 2019
13F-HR7$388.4K2019-11-14SEC ↗
Q2 2019
13F-HR5$196.9K2019-08-14SEC ↗
Q1 2019
13F-HR6$250.1K2019-05-15SEC ↗
Q4 2018
13F-HR6$292.6K2019-02-14SEC ↗
Q3 2018
13F-HR6$440.6K2018-11-14SEC ↗
Q2 2018
13F-HR5$319.1K2018-08-14SEC ↗
Q1 2018
13F-HR4$169.6K2018-05-15SEC ↗
Q4 2017
13F-HR3$152.4K2018-02-14SEC ↗